Navigation Links
Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients
Date:1/4/2011

h the introduction of new medicines.  Anadys has initiated a Phase IIb study of ANA598, the Company's DAA, added to current standard of care for the treatment of hepatitis C.  The Company is also preparing to resume clinical development of ANA773, the Company's oral, small-molecule inducer of endogenous interferons that acts via the Toll like receptor 7, or TLR7, pathway in hepatitis C.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements."  Such statements include, but are not limited to, references to (i) expectations regarding the timing for commencing patient dosing in the ANA598 Phase IIb study; (ii) the goal of establishing safety and efficacy in a greater number of patients, including those who have failed prior HCV treatment; (iii) the hope to position ANA598 as a highly attractive HCV agent ready for Phase III development; (iv) the scheduled trial design for the Phase IIb study; and (v) Anadys' expectations regarding the timing of receipt of data from the study.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements.  For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 will not have unforeseen safety issues, will have favorable results in ongoing or future clinical trials or will receive regulatory approval.  In addition, Anadys' results may be affected by competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to enter into transactions around its product candidates, its ability to successfully develop and market products, difficultie
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
2. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
3. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
4. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Anadys Pharmaceuticals to Present at the BMO Capital Markets Healthcare Conference
6. Anadys Pharmaceuticals to Report Second Quarter 2010 Financial Results
7. Anadys Retains Lazard as Strategic Advisor
8. Anadys Pharmaceuticals to Present at the ROTH OC Growth Stock Conference
9. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
10. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
11. Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  Volcano Corporation (Nasdaq: VOLC ), ... economic outcomes on a global basis by developing ... visualization, physiology diagnostics and therapies, said today that ... Healthcare conference on Tuesday, September 9. ... and chief executive officer, will begin at 11:10 ...
(Date:9/2/2014)... , Sept. 2, 2014  VentiRx Pharmaceuticals, ... to the development and commercialization of novel ... an update on corporate and clinical activities ... for future funding, ongoing clinical trials and ... In corporate news, Chief Executive Officer Robert ...
(Date:9/2/2014)... SEATTLE , Sept. 2, 2014 /PRNewswire/ ... company committed to the development and commercialization ... today announced that the U.S. Food and ... designation to the investigation of motolimod (VTX-2337) ... doxorubicin (PLD) for the treatment of women ...
Breaking Medicine Technology:VentiRx Pharmaceuticals Provides Corporate and Clinical Update 2VentiRx Pharmaceuticals Provides Corporate and Clinical Update 3VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer 2VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer 3
... 5, 2011 Reportlinker.com announces that ... available in its catalogue: ... Cosmetic Surgery, Facial Aesthetic and Medical ... http://www.reportlinker.com/p0610527/Emerging-Markets-Chinese-and-Indian-Cosmetic-Surgery-Facial-Aesthetic-and-Medical-Laser-Markets-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply The ...
... 2011 The Board of Directors of MSA (NYSE: ... a Vice President of the company, responsible for Global Product ... of November 1, will assume the role of President of ... (MEZ).  In his new role, Dr. Muschter will become a ...
Cached Medicine Technology:Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 2Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 3Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 4Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 5Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 6Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 7Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 8Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 9Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 10Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 11Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 12Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 13Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 14Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 15Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 16Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 17Emerging Markets: Chinese and Indian Cosmetic Surgery, Facial Aesthetic and Medical Laser Markets 2011 18MSA Elects Dr. Thomas Muschter to Vice President 2
(Date:9/2/2014)... September 02, 2014 Nanomedicine is ... in diagnosing, treating and/or prevention of diseases and ... treating cardiovascular, neurological, and oncology diseases. , ... pertaining to various nanoparticles, their medical usages, and ... exists considerable scope for research in this domain, ...
(Date:9/2/2014)... On Saturday, September 6, 2014, The Concilio will present ... vida! Get Up! Get Moving!®. This event promotes Hispanic family ... for people of all ages and all sizes. The event, ... held at Kiest Park Recreation Center, 3080 S. Hampton Road, ... “Since 2007, we have partnered with National Alliance for Hispanic ...
(Date:9/2/2014)... Durable Medical Goods manufacture ThermoTek ... and financing company LeaseQ, Inc. to help customers acquire ... late 2012, LeaseQ’s breakthrough finance shopping platform has enabled ... need to run their business. , Said LeaseQ ... the ThermoTek sales team to provide customers faster access ...
(Date:9/2/2014)... September 02, 2014 The American Healthcare ... a Free-Tuition Guarantee for its ICD-10 Medical Coding Bridge ... the highest level of confidence to students who are ... coder, but are faced with the uncertainty brought on ... of ICD-10 until October 1st, 2015. , AHDPG’s Free-Tuition ...
(Date:9/2/2014)... (HealthDay News) -- The quality of Americans, diets has ... between the rich and poor is growing, a new ... evidence to date that the extensive efforts by many ... having some payoff, but it also indicates that these ... a doctoral student in the department of nutrition at ...
Breaking Medicine News(10 mins):Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 3Health News:The Concilio Presents Eighth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:The Concilio Presents Eighth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:The Concilio Presents Eighth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 3Health News:Quality of U.S. Diet Improves, Slightly 2
... take cues from hues, study finds, , , THURSDAY, Feb. 5 ... Want to be more creative at work? Paint your office ... analyzed the effect of color on 666 students, 17 ... presented on computer screens set to either a red, blue ...
... of human leukemia has provided critical insight into the genetic ... stem cells. The study, published by Cell Press in the ... , is likely to have a profound impact on the ... , Leukemia stem cells (LSCs) were initially described as rare ...
... Free or Discounted Care , ... Tampa, Fla. (PRWEB) ... medical officer and internal medicine specialist of Florida Veterinary Specialists ... Times." Shaw met with People Magazine to talk about the ...
... Feb. 5 The National Patient Advocate ... the mission of creating avenues of improved patient access ... state and federal levels -- today praised Congress for ... Health Insurance Program, or SCHIP, which will extend health ...
... the next 12,weeks eDiets and ExerciseTV will provide ... personalized fitness plans,using the free video-on-demand (VOD) ... to share their weight loss journey with the,world. ... than 1500 applicants, the four Make Me Over ...
... early detection of disease, A Su Salud revealed high ... participants and provided $55 million in free and low ... /PRNewswire/ -- CVS/pharmacy, the ... of "A Su Salud" (To Your Health) health fairs, ...
Cached Medicine News:Health News:Color Can Affect How People Think and Act 2Health News:Color Can Affect How People Think and Act 3Health News:Leukemia stem cells have more in common with embryonic stem cells than adult stem cells 2Health News:Tampa Bay Veterinarian Featured in People Magazine's Heroes in Hard Times 2Health News:Tampa Bay Veterinarian Featured in People Magazine's Heroes in Hard Times 3Health News:National Patient Advocate Foundation Applauds Congress' and President Obama's Decision to Extend Health Coverage to Four Million Uninsured Children 2Health News:How Much Weight Can They Lose in 90 Days? 2Health News:How Much Weight Can They Lose in 90 Days? 3Health News:CVS/pharmacy Launches 2009 'A Su Salud' Health Fairs Providing Free Health Screenings to the Community 2Health News:CVS/pharmacy Launches 2009 'A Su Salud' Health Fairs Providing Free Health Screenings to the Community 3
... KIMBERLY-CLARK BALLARD Adult TRACH ... in T-Piece, Elbow and Double ... separate from vials; 12 vials ... Offers multiple tracheostomy sizes, French ...
... KIMBERLY-CLARK BALLARD Adult TRACH ... designed and labeled for ... Features an isolated cleaning ... minimize potential for contamination ...
... Maxi-Flo® suction catheters ... or straight. , ... catheter kits are latex-free., ... feature a catheter tip ...
... are available with a single lumen or ... swivel, MDI adapter., ,Trac-Wedge™ device, and ... include a patient label. Dual swivel elbow ... All Portex® Steri-Cath® systems are latex-free. , ...
Medicine Products: